Brazil

Recordati Rare Diseases Brazil has been commercially present in Brazil since 2019, operating in three areas targeting rare diseases: inborn errors of metabolism, endocrinology and oncology. 

With the expansion of our activities, In 2022 our new office was inaugurated, from where we manage the importation, warehousing, logistics, promotion and sales of our medicines, alongside with medical education and other supporting activities to the rare diseases’ community in Brazil. 

As of now Recordati has seven therapies available on its local portfolio, including treatments for organic acidemias, acromegaly, Cushing’s disease, Castleman’s multicentric idiopathic disease, neuroblastoma, porphyria, and treatment for canal arterial permeability.

Since its establishment, Recordati Rare Diseases Brazil has collaborated with healthcare professionals, patient organizations, and authorities to improve diagnosis, treatment, and patient outcomes in the field of rare diseases.